PESTORIN MORMYX liofilizāts un suspensija suspensijas injekcijām pagatavošanai trušiem
PESTORIN MORMYX liofilizāts un suspensija suspensijas injekcijām pagatavošanai trušiem
Authorised
- Myxoma virus, strain CAMP V-219, Live
- Rabbit haemorrhagic disease virus, type 1, strain CAMP V-351, Inactivated
Product identification
Medicine name:
PESTORIN MORMYX liofilizāts un suspensija suspensijas injekcijām pagatavošanai trušiem
Active substance:
- Myxoma virus, strain CAMP V-219, Live
- Rabbit haemorrhagic disease virus, type 1, strain CAMP V-351, Inactivated
Target species:
-
Rabbit
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Myxoma virus, strain CAMP V-219, Live630957.00/50% tissue culture infectious dose1.00unit(s)
-
Rabbit haemorrhagic disease virus, type 1, strain CAMP V-351, Inactivated1024.00/unit(s)1.00unit(s)
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Rabbit
-
Meat and offal7dayIespējama lokāla audu reakcija, kura izzūd 7 dienu laikā.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AH01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/01/1335
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 12/06/2025